|
|
Vaccine Detail
|
DAPTACEL |
| Vaccine Information |
- Vaccine Name: DAPTACEL
- Target Pathogen: Bordetella pertussis
- Target Disease: Whooping Cough
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
- Tradename: DAPTACEL
- Manufacturer: Sanofi Pasteur, Ltd.
- Vaccine Ontology ID: VO_0000029
- CDC CVX code: 20, 106
- Type: Toxoid vaccine
- Status: Licensed
- Location Licensed: USA (License #1726)
- Host Species for Licensed Use: Human
- Antigen: Isotonic suspension of pertussis antigens and diphtheria and tetanus toxoids (FDA: DAPTACEL).
- Adjuvant:
- Adjuvant name:
- VO adjuvant ID: VO_0000128
- Description: DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age.
- Preparation: Clostridium tetani is grown in modified Mueller-Miller casamino acid medium without beef heart infusion. Tetanus toxin is detoxified with formaldehyde and purified by ammonium sulfate fractionation and diafiltration (FDA: DAPTACEL).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Should be stored at 2° to 8°C (35° to 46°F). DO NOT FREEZE.
- Approved Age for Licensed Use: DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus and pertussis as a five dose series in infants and children 6 weeks through 6 years of age (prior to 7th birthday) (FDA: DAPTACEL).
- Contraindication: Severe allergic reaction (e.g. anaphylaxis) after a previous dose of any diphtheria toxoid, tetanus toxoid, or pertussis-containing vaccine, or any component of DAPTACEL, encephalopathy within 7 days of a previous pertussis-containing vaccine with no other identifiable cause and, progressive neurologic disorder until a treatment regimen has been established and the condition has stabilized (FDA: DAPTACEL).
- Description: DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age.
|
| Host Response |
|
|
| References |
FDA: DAPTACEL: FDA: DAPTACEL [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101572.htm]
|
|
